Atrys IMOR is a monographic centre specialising in oncology patient care. Dedicated to carrying out treatments in the speciality of Radiotherapy Oncology, it is committed to performing them in accordance with the highest internationally accepted quality standards. It began its activity in 1999 and since then has attended to more than 13,000 patients.
Our work revolves around three fundamental pillars for patients and for us: facilitating your recovery and supporting you with outstanding professionals through the latest technological advances.
Precision medicine, prevention, prediction and personalised medicine are the fundamental pillars that must be supported in order to provide adequate and comprehensive care for cancer patients.
The monographic centres that make up our Atrys Oncology Network in Spain, Switzerland and Portugal offer cancer patients a comprehensive response, with the best specialists and the most advanced diagnostic and treatment resources available.
Atrys IMOR has the most modern and up-to-date external radiotherapy and brachytherapy equipment, performing treatments according to the best state of the art. Most of the external radiotherapy treatments are carried out using the IMRT technique combined with IGRT, Intensity Modulated Radiotherapy and Image Guided Radiotherapy, the most precise technique currently available, which increases cures while reducing side effects and minimising complications.
Among the Radiotherapy techniques it has introduced in Spain the Rapid Arc technique, which even improves IMRT by shortening treatment time, and the recently introduced SBRT technique which offers spectacular results in the treatment of lung tumours and distant metastases located in the vicinity of critical organs.
Atrys IMOR stands out not only for the high quality of the medical treatments it provides, but also for the human treatment it offers. Proof of this is the high level of satisfaction of the patients we treat as well as the insurance companies that refer their patients to us, some of which have recognised us as their reference centre.
In short, at Atrys Oncology we firmly believe in incorporating new technologies into daily clinical practice as soon as possible, as long as we have previously ensured that their use is justified and benefits the patient. We have to make sure that from the first moment their application is carried out properly, without learning curves, which is why important continuous training is necessary. In order for these techniques to be applied, it is necessary to have adequate reimbursement, so that they can be incorporated as they arise. Our staff is scientifically active, participating in the most important congresses in the speciality, presenting their scientific work and publishing their results in high impact journals in the speciality. Finally, the work of Atrys oncology must be adequately disseminated so that the authorities, payers, patients, healthcare staff and the general public are aware of its existence and can come to it for as many consultations as they deem necessary.
For all this to become a reality, EFFORT is needed, which Atrys IMOR is committed to do.
Atrys IMOR is owned by Atrys Health and managed by specialists in Radiation Oncology and Hospital Radiophysics. The resources generated are reinvested in order to ensure that the most advanced treatment techniques are available at all times and can be offered to patients.
It has been distinguished with the highest international awards in the speciality, having received the Best Brachytherapy Award from the World Congress of Brachytherapy, the Best Radiotherapy Center from the European Society for Radiotherapy and Oncology (ESTRO) and the Juditt Sitt Brachytherapy Prize from the American Brachytherapy Society (ABS) among others.
The multidisciplinary team is made up of leading experts in each of the branches of the speciality. Directed by Dr. Benjamín Guix, Professor of Radiology and Physical Medicine at the University of Barcelona, it has two full-time specialists, Dr. Emma González and Dr. Iván García. Part-time collaborators are Dr. Ferrán Guedea, Head of the Radiotherapy Service of the Catalan Institute of Oncology of the Duran i Reynals Hospital and former president of the Spanish Society of Radiation Oncology (SEOR), Dr. Manel Algara, Head of the Radiation Oncology Service of the Hospital de la Esperanza, Dr. Josep María Solé, Head of the Radiation Oncology Service of the Hospital del Vallés and Dr. Lluís Quinzaños, a doctor specialising in family and community medicine.
The Medical Physics and Radiation Protection Service is made up of Mr. José Ignacio Tello, specialist in hospital radiophysics, and Lucia Franco, specialist in hospital radiophysics, who are in charge of keeping all the complex installations up to date and guaranteeing the quality of the treatments.
We also have a specialist in gynaecological oncology, a urologist and an anaesthetist, who collaborate in brachytherapy treatments to ensure the highest levels of precision and quality at all times, and a specialist in psycho-oncology.
The Centre's management is headed by Mrs. Mariángeles Tapia, and the team is completed by a total of 8 radiotherapy and dosimetry specialists, 3 part-time nurses and 3 secretaries.
Start of activity: 1999 Care data more than 13000 patients attended to Prostate brachytherapy more than 4000 patients Human resources 25 Medical staff 18 Technological resources The Centre is equipped with all the latest technological innovations. Physical resources Care centres: 2
Dr. Benjamín Guix Melcior
Manager of the IMOR Institute Doctor of Medicine and Specialist in Radiation Oncology Associate Lecturer at the Autonomous University of Barcelona
Dr. Ferran Guedea Edo
One of the leading experts in radiotherapy of breast, gynaecological and cervical tumours. Doctorate Cum Laude and recognised by awards such as the Ernest Lluch Prize and the Gold Medal of the SFRO (Société Française de Radiothérapie Oncologique). In addition, he is a university lecturer and past president of the Spanish Society of Radiation Oncology.
Dr. Manuel Algara
Expert in the treatment of breast neoplasms, blood and lung as well as palliative radiotherapy. After more than 25 years of experience he has held various positions of responsibility and has served as a university professor.
08 Apr 2020
10 Apr 2017
01 Aug 2016
28 Jul 2016
22 Jun 2016
08 Jan 2016
01 Sep 2015
15 Jun 2015
07 Apr 2015
01 Apr 2015
26 Mar 2015
05 Mar 2015
24 Feb 2015
12 May 2014
12 May 2014
28 Jan 2014